雅仕維(01993.HK)與京港地鐵訂立北京地鐵4號線及大興線獨家代理經營權協議
格隆匯 12 月 31日丨雅仕維(01993.HK)公吿,於2020年12月31日,(i)上海雅仕維(公司全資附屬公司)與京港地鐵訂立北京地鐵4號線及大興線獨家代理經營權協議,據此上海雅仕維獲授予獨家權以使用及營運由京港地鐵營運北京地鐵4號綫及大興綫廣吿及媒體資源,並向京港地鐵支付特許經營費;及(ii)上海雅仕維與京港地鐵十六(京港地鐵全資附屬公司)訂立北京地鐵16號綫獨家代理經營權協議,據此上海雅仕維獲授予獨家權以使用及營運由京港地鐵十六營運北京地鐵16號綫廣吿及媒體資源,並向京港地鐵十六支付特許經營費。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.